HEADER TRANSFERASE/TRANSFERASE INHIBITOR 22-DEC-12 4IJP TITLE CRYSTAL STRUCTURE OF HUMAN PRPF4B KINASE DOMAIN IN COMPLEX WITH 4-{5- TITLE 2 [(2-CHLORO-PYRIDIN-4-YLMETHYL)-CARBAMOYL]-THIOPHEN-2-YL}- TITLE 3 BENZO[B]THIOPHENE-2-CARBOXYLIC ACID AMINE COMPND MOL_ID: 1; COMPND 2 MOLECULE: SERINE/THREONINE-PROTEIN KINASE PRP4 HOMOLOG; COMPND 3 CHAIN: A, B; COMPND 4 FRAGMENT: KINASE DOMAIN; COMPND 5 SYNONYM: PRP4 KINASE, PRP4 PRE-MRNA-PROCESSING FACTOR 4 HOMOLOG; COMPND 6 EC: 2.7.11.1; COMPND 7 ENGINEERED: YES SOURCE MOL_ID: 1; SOURCE 2 ORGANISM_SCIENTIFIC: HOMO SAPIENS; SOURCE 3 ORGANISM_COMMON: HUMAN; SOURCE 4 ORGANISM_TAXID: 9606; SOURCE 5 GENE: KIAA0536, PRP4, PRP4H, PRP4K, PRPF4B; SOURCE 6 EXPRESSION_SYSTEM: SPODOPTERA FRUGIPERDA; SOURCE 7 EXPRESSION_SYSTEM_TAXID: 7108; SOURCE 8 EXPRESSION_SYSTEM_STRAIN: SF9; SOURCE 9 EXPRESSION_SYSTEM_VECTOR_TYPE: PLASMID; SOURCE 10 EXPRESSION_SYSTEM_PLASMID: PFASTBAC1 KEYWDS KINASE, TRANSFERASE, TRANSFERASE-TRANSFERASE INHIBITOR COMPLEX EXPDTA X-RAY DIFFRACTION AUTHOR I.MECHIN,K.HAAS,X.CHEN,Y.ZHANG,L.MCLEAN REVDAT 4 15-NOV-17 4IJP 1 REMARK REVDAT 3 06-NOV-13 4IJP 1 JRNL REVDAT 2 18-SEP-13 4IJP 1 JRNL REVDAT 1 28-AUG-13 4IJP 0 JRNL AUTH Q.GAO,I.MECHIN,N.KOTHARI,Z.GUO,G.DENG,K.HAAS,J.MCMANUS, JRNL AUTH 2 D.HOFFMANN,A.WANG,D.WIEDERSCHAIN,J.ROCNIK,W.CZECHTIZKY, JRNL AUTH 3 X.CHEN,L.MCLEAN,H.ARLT,D.HARPER,F.LIU,T.MAJID,V.PATEL, JRNL AUTH 4 C.LENGAUER,C.GARCIA-ECHEVERRIA,B.ZHANG,H.CHENG,M.DORSCH, JRNL AUTH 5 S.M.HUANG JRNL TITL EVALUATION OF CANCER DEPENDENCE AND DRUGGABILITY OF PRP4 JRNL TITL 2 KINASE USING CELLULAR, BIOCHEMICAL, AND STRUCTURAL JRNL TITL 3 APPROACHES. JRNL REF J.BIOL.CHEM. V. 288 30125 2013 JRNL REFN ISSN 0021-9258 JRNL PMID 24003220 JRNL DOI 10.1074/JBC.M113.473348 REMARK 2 REMARK 2 RESOLUTION. 2.25 ANGSTROMS. REMARK 3 REMARK 3 REFINEMENT. REMARK 3 PROGRAM : BUSTER-TNT BUSTER 2.9.1 REMARK 3 AUTHORS : BRICOGNE,BLANC,BRANDL,FLENSBURG,KELLER, REMARK 3 : PACIOREK,ROVERSI,SHARFF,SMART,VONRHEIN, REMARK 3 : WOMACK,MATTHEWS,TEN EYCK,TRONRUD REMARK 3 REMARK 3 DATA USED IN REFINEMENT. REMARK 3 RESOLUTION RANGE HIGH (ANGSTROMS) : 2.25 REMARK 3 RESOLUTION RANGE LOW (ANGSTROMS) : 47.61 REMARK 3 DATA CUTOFF (SIGMA(F)) : 0.000 REMARK 3 COMPLETENESS FOR RANGE (%) : 98.3 REMARK 3 NUMBER OF REFLECTIONS : 36691 REMARK 3 REMARK 3 FIT TO DATA USED IN REFINEMENT. REMARK 3 CROSS-VALIDATION METHOD : THROUGHOUT REMARK 3 FREE R VALUE TEST SET SELECTION : RANDOM REMARK 3 R VALUE (WORKING + TEST SET) : 0.250 REMARK 3 R VALUE (WORKING SET) : 0.250 REMARK 3 FREE R VALUE : 0.265 REMARK 3 FREE R VALUE TEST SET SIZE (%) : 4.990 REMARK 3 FREE R VALUE TEST SET COUNT : 1832 REMARK 3 ESTIMATED ERROR OF FREE R VALUE : NULL REMARK 3 REMARK 3 FIT IN THE HIGHEST RESOLUTION BIN. REMARK 3 TOTAL NUMBER OF BINS USED : 18 REMARK 3 BIN RESOLUTION RANGE HIGH (ANGSTROMS) : 2.25 REMARK 3 BIN RESOLUTION RANGE LOW (ANGSTROMS) : 2.31 REMARK 3 BIN COMPLETENESS (WORKING+TEST) (%) : 98.27 REMARK 3 REFLECTIONS IN BIN (WORKING + TEST SET) : 2930 REMARK 3 BIN R VALUE (WORKING + TEST SET) : 0.2728 REMARK 3 REFLECTIONS IN BIN (WORKING SET) : 2771 REMARK 3 BIN R VALUE (WORKING SET) : 0.2734 REMARK 3 BIN FREE R VALUE : 0.2630 REMARK 3 BIN FREE R VALUE TEST SET SIZE (%) : 5.43 REMARK 3 BIN FREE R VALUE TEST SET COUNT : 159 REMARK 3 ESTIMATED ERROR OF BIN FREE R VALUE : NULL REMARK 3 REMARK 3 NUMBER OF NON-HYDROGEN ATOMS USED IN REFINEMENT. REMARK 3 PROTEIN ATOMS : 5440 REMARK 3 NUCLEIC ACID ATOMS : 0 REMARK 3 HETEROGEN ATOMS : 86 REMARK 3 SOLVENT ATOMS : 173 REMARK 3 REMARK 3 B VALUES. REMARK 3 FROM WILSON PLOT (A**2) : NULL REMARK 3 MEAN B VALUE (OVERALL, A**2) : 51.24 REMARK 3 OVERALL ANISOTROPIC B VALUE. REMARK 3 B11 (A**2) : 3.43870 REMARK 3 B22 (A**2) : 5.60000 REMARK 3 B33 (A**2) : -9.03870 REMARK 3 B12 (A**2) : 6.86180 REMARK 3 B13 (A**2) : 2.54070 REMARK 3 B23 (A**2) : -12.56250 REMARK 3 REMARK 3 ESTIMATED COORDINATE ERROR. REMARK 3 ESD FROM LUZZATI PLOT (A) : 0.401 REMARK 3 DPI (BLOW EQ-10) BASED ON R VALUE (A) : NULL REMARK 3 DPI (BLOW EQ-9) BASED ON FREE R VALUE (A) : NULL REMARK 3 DPI (CRUICKSHANK) BASED ON R VALUE (A) : 0.362 REMARK 3 DPI (CRUICKSHANK) BASED ON FREE R VALUE (A) : NULL REMARK 3 REMARK 3 REFERENCES: BLOW, D. (2002) ACTA CRYST D58, 792-797 REMARK 3 CRUICKSHANK, D.W.J. (1999) ACTA CRYST D55, 583-601 REMARK 3 REMARK 3 CORRELATION COEFFICIENTS. REMARK 3 CORRELATION COEFFICIENT FO-FC : NULL REMARK 3 CORRELATION COEFFICIENT FO-FC FREE : NULL REMARK 3 REMARK 3 NUMBER OF GEOMETRIC FUNCTION TERMS DEFINED : 15 REMARK 3 TERM COUNT WEIGHT FUNCTION. REMARK 3 BOND LENGTHS : 5644 ; 2.000 ; HARMONIC REMARK 3 BOND ANGLES : 7607 ; 2.000 ; HARMONIC REMARK 3 TORSION ANGLES : 2039 ; 2.000 ; SINUSOIDAL REMARK 3 TRIGONAL CARBON PLANES : 153 ; 2.000 ; HARMONIC REMARK 3 GENERAL PLANES : 794 ; 5.000 ; HARMONIC REMARK 3 ISOTROPIC THERMAL FACTORS : 5582 ; 20.000 ; HARMONIC REMARK 3 BAD NON-BONDED CONTACTS : 0 ; 5.000 ; SEMIHARMONIC REMARK 3 IMPROPER TORSIONS : NULL ; NULL ; NULL REMARK 3 PSEUDOROTATION ANGLES : NULL ; NULL ; NULL REMARK 3 CHIRAL IMPROPER TORSION : 697 ; 5.000 ; SEMIHARMONIC REMARK 3 SUM OF OCCUPANCIES : NULL ; NULL ; NULL REMARK 3 UTILITY DISTANCES : NULL ; NULL ; NULL REMARK 3 UTILITY ANGLES : NULL ; NULL ; NULL REMARK 3 UTILITY TORSION : NULL ; NULL ; NULL REMARK 3 IDEAL-DIST CONTACT TERM : 6513 ; 4.000 ; SEMIHARMONIC REMARK 3 REMARK 3 RMS DEVIATIONS FROM IDEAL VALUES. REMARK 3 BOND LENGTHS (A) : 0.008 REMARK 3 BOND ANGLES (DEGREES) : 1.01 REMARK 3 PEPTIDE OMEGA TORSION ANGLES (DEGREES) : 1.59 REMARK 3 OTHER TORSION ANGLES (DEGREES) : 19.76 REMARK 3 REMARK 3 TLS DETAILS REMARK 3 NUMBER OF TLS GROUPS : NULL REMARK 3 REMARK 3 OTHER REFINEMENT REMARKS: NULL REMARK 4 REMARK 4 4IJP COMPLIES WITH FORMAT V. 3.30, 13-JUL-11 REMARK 100 REMARK 100 THIS ENTRY HAS BEEN PROCESSED BY RCSB ON 03-JAN-13. REMARK 100 THE DEPOSITION ID IS D_1000076837. REMARK 200 REMARK 200 EXPERIMENTAL DETAILS REMARK 200 EXPERIMENT TYPE : X-RAY DIFFRACTION REMARK 200 DATE OF DATA COLLECTION : 13-JUN-11 REMARK 200 TEMPERATURE (KELVIN) : 100 REMARK 200 PH : 7.0 REMARK 200 NUMBER OF CRYSTALS USED : 1 REMARK 200 REMARK 200 SYNCHROTRON (Y/N) : Y REMARK 200 RADIATION SOURCE : APS REMARK 200 BEAMLINE : 21-ID-F REMARK 200 X-RAY GENERATOR MODEL : NULL REMARK 200 MONOCHROMATIC OR LAUE (M/L) : M REMARK 200 WAVELENGTH OR RANGE (A) : 0.979 REMARK 200 MONOCHROMATOR : NULL REMARK 200 OPTICS : NULL REMARK 200 REMARK 200 DETECTOR TYPE : CCD REMARK 200 DETECTOR MANUFACTURER : MARMOSAIC 225 MM CCD REMARK 200 INTENSITY-INTEGRATION SOFTWARE : DENZO REMARK 200 DATA SCALING SOFTWARE : SCALEPACK REMARK 200 REMARK 200 NUMBER OF UNIQUE REFLECTIONS : 36692 REMARK 200 RESOLUTION RANGE HIGH (A) : 2.250 REMARK 200 RESOLUTION RANGE LOW (A) : 50.000 REMARK 200 REJECTION CRITERIA (SIGMA(I)) : NULL REMARK 200 REMARK 200 OVERALL. REMARK 200 COMPLETENESS FOR RANGE (%) : 98.4 REMARK 200 DATA REDUNDANCY : 2.300 REMARK 200 R MERGE (I) : 0.05100 REMARK 200 R SYM (I) : NULL REMARK 200 FOR THE DATA SET : 8.5000 REMARK 200 REMARK 200 IN THE HIGHEST RESOLUTION SHELL. REMARK 200 HIGHEST RESOLUTION SHELL, RANGE HIGH (A) : 2.25 REMARK 200 HIGHEST RESOLUTION SHELL, RANGE LOW (A) : 2.33 REMARK 200 COMPLETENESS FOR SHELL (%) : 97.5 REMARK 200 DATA REDUNDANCY IN SHELL : 2.30 REMARK 200 R MERGE FOR SHELL (I) : 0.42700 REMARK 200 R SYM FOR SHELL (I) : NULL REMARK 200 FOR SHELL : NULL REMARK 200 REMARK 200 DIFFRACTION PROTOCOL: SINGLE WAVELENGTH REMARK 200 METHOD USED TO DETERMINE THE STRUCTURE: MOLECULAR REPLACEMENT REMARK 200 SOFTWARE USED: NULL REMARK 200 STARTING MODEL: NULL REMARK 200 REMARK 200 REMARK: NULL REMARK 280 REMARK 280 CRYSTAL REMARK 280 SOLVENT CONTENT, VS (%): 49.19 REMARK 280 MATTHEWS COEFFICIENT, VM (ANGSTROMS**3/DA): 2.42 REMARK 280 REMARK 280 CRYSTALLIZATION CONDITIONS: 0.2M AMMONIUM SULFATE, 20-30% PEG 3350 REMARK 280 AND 0.1M HEPES PH7.0 5 MM COMPOUND FINAL CONCENTRATION ADDED TO REMARK 280 CRYO-PROTECTANT SOLUTION FOR SOAKING OF APO CRYSTALS, VAPOR REMARK 280 DIFFUSION, HANGING DROP, TEMPERATURE 291K REMARK 290 REMARK 290 CRYSTALLOGRAPHIC SYMMETRY REMARK 290 SYMMETRY OPERATORS FOR SPACE GROUP: P 1 REMARK 290 REMARK 290 SYMOP SYMMETRY REMARK 290 NNNMMM OPERATOR REMARK 290 1555 X,Y,Z REMARK 290 REMARK 290 WHERE NNN -> OPERATOR NUMBER REMARK 290 MMM -> TRANSLATION VECTOR REMARK 290 REMARK 290 CRYSTALLOGRAPHIC SYMMETRY TRANSFORMATIONS REMARK 290 THE FOLLOWING TRANSFORMATIONS OPERATE ON THE ATOM/HETATM REMARK 290 RECORDS IN THIS ENTRY TO PRODUCE CRYSTALLOGRAPHICALLY REMARK 290 RELATED MOLECULES. REMARK 290 SMTRY1 1 1.000000 0.000000 0.000000 0.00000 REMARK 290 SMTRY2 1 0.000000 1.000000 0.000000 0.00000 REMARK 290 SMTRY3 1 0.000000 0.000000 1.000000 0.00000 REMARK 290 REMARK 290 REMARK: NULL REMARK 300 REMARK 300 BIOMOLECULE: 1, 2 REMARK 300 SEE REMARK 350 FOR THE AUTHOR PROVIDED AND/OR PROGRAM REMARK 300 GENERATED ASSEMBLY INFORMATION FOR THE STRUCTURE IN REMARK 300 THIS ENTRY. THE REMARK MAY ALSO PROVIDE INFORMATION ON REMARK 300 BURIED SURFACE AREA. REMARK 350 REMARK 350 COORDINATES FOR A COMPLETE MULTIMER REPRESENTING THE KNOWN REMARK 350 BIOLOGICALLY SIGNIFICANT OLIGOMERIZATION STATE OF THE REMARK 350 MOLECULE CAN BE GENERATED BY APPLYING BIOMT TRANSFORMATIONS REMARK 350 GIVEN BELOW. BOTH NON-CRYSTALLOGRAPHIC AND REMARK 350 CRYSTALLOGRAPHIC OPERATIONS ARE GIVEN. REMARK 350 REMARK 350 BIOMOLECULE: 1 REMARK 350 AUTHOR DETERMINED BIOLOGICAL UNIT: MONOMERIC REMARK 350 SOFTWARE DETERMINED QUATERNARY STRUCTURE: MONOMERIC REMARK 350 SOFTWARE USED: PISA REMARK 350 APPLY THE FOLLOWING TO CHAINS: A REMARK 350 BIOMT1 1 1.000000 0.000000 0.000000 0.00000 REMARK 350 BIOMT2 1 0.000000 1.000000 0.000000 0.00000 REMARK 350 BIOMT3 1 0.000000 0.000000 1.000000 0.00000 REMARK 350 REMARK 350 BIOMOLECULE: 2 REMARK 350 AUTHOR DETERMINED BIOLOGICAL UNIT: MONOMERIC REMARK 350 SOFTWARE DETERMINED QUATERNARY STRUCTURE: MONOMERIC REMARK 350 SOFTWARE USED: PISA REMARK 350 APPLY THE FOLLOWING TO CHAINS: B REMARK 350 BIOMT1 1 1.000000 0.000000 0.000000 0.00000 REMARK 350 BIOMT2 1 0.000000 1.000000 0.000000 0.00000 REMARK 350 BIOMT3 1 0.000000 0.000000 1.000000 0.00000 REMARK 465 REMARK 465 MISSING RESIDUES REMARK 465 THE FOLLOWING RESIDUES WERE NOT LOCATED IN THE REMARK 465 EXPERIMENT. (M=MODEL NUMBER; RES=RESIDUE NAME; C=CHAIN REMARK 465 IDENTIFIER; SSSEQ=SEQUENCE NUMBER; I=INSERTION CODE.) REMARK 465 REMARK 465 M RES C SSSEQI REMARK 465 MET A 656 REMARK 465 ASP A 657 REMARK 465 PHE A 658 REMARK 465 LYS A 659 REMARK 465 GLU A 660 REMARK 465 ASN A 661 REMARK 465 PRO A 662 REMARK 465 ASN A 663 REMARK 465 LEU A 664 REMARK 465 ARG A 665 REMARK 465 ASP A 666 REMARK 465 ASN A 667 REMARK 465 TRP A 668 REMARK 465 THR A 669 REMARK 465 LYS A 936 REMARK 465 VAL A 937 REMARK 465 THR A 938 REMARK 465 GLY A 961 REMARK 465 CYS A 962 REMARK 465 LYS A 1006 REMARK 465 ILE A 1007 REMARK 465 HIS A 1008 REMARK 465 HIS A 1009 REMARK 465 HIS A 1010 REMARK 465 HIS A 1011 REMARK 465 HIS A 1012 REMARK 465 HIS A 1013 REMARK 465 MET B 656 REMARK 465 ASP B 657 REMARK 465 PHE B 658 REMARK 465 LYS B 659 REMARK 465 GLU B 660 REMARK 465 ASN B 661 REMARK 465 PRO B 662 REMARK 465 ASN B 663 REMARK 465 LEU B 664 REMARK 465 ARG B 665 REMARK 465 ASP B 666 REMARK 465 ASN B 667 REMARK 465 LYS B 936 REMARK 465 VAL B 937 REMARK 465 THR B 938 REMARK 465 GLU B 939 REMARK 465 LYS B 1006 REMARK 465 ILE B 1007 REMARK 465 HIS B 1008 REMARK 465 HIS B 1009 REMARK 465 HIS B 1010 REMARK 465 HIS B 1011 REMARK 465 HIS B 1012 REMARK 465 HIS B 1013 REMARK 500 REMARK 500 GEOMETRY AND STEREOCHEMISTRY REMARK 500 SUBTOPIC: COVALENT BOND ANGLES REMARK 500 REMARK 500 THE STEREOCHEMICAL PARAMETERS OF THE FOLLOWING RESIDUES REMARK 500 HAVE VALUES WHICH DEVIATE FROM EXPECTED VALUES BY MORE REMARK 500 THAN 6*RMSD (M=MODEL NUMBER; RES=RESIDUE NAME; C=CHAIN REMARK 500 IDENTIFIER; SSEQ=SEQUENCE NUMBER; I=INSERTION CODE). REMARK 500 REMARK 500 STANDARD TABLE: REMARK 500 FORMAT: (10X,I3,1X,A3,1X,A1,I4,A1,3(1X,A4,2X),12X,F5.1) REMARK 500 REMARK 500 EXPECTED VALUES PROTEIN: ENGH AND HUBER, 1999 REMARK 500 EXPECTED VALUES NUCLEIC ACID: CLOWNEY ET AL 1996 REMARK 500 REMARK 500 M RES CSSEQI ATM1 ATM2 ATM3 REMARK 500 VAL A 697 C - N - CA ANGL. DEV. = 15.6 DEGREES REMARK 500 REMARK 500 REMARK: NULL REMARK 500 REMARK 500 GEOMETRY AND STEREOCHEMISTRY REMARK 500 SUBTOPIC: TORSION ANGLES REMARK 500 REMARK 500 TORSION ANGLES OUTSIDE THE EXPECTED RAMACHANDRAN REGIONS: REMARK 500 (M=MODEL NUMBER; RES=RESIDUE NAME; C=CHAIN IDENTIFIER; REMARK 500 SSEQ=SEQUENCE NUMBER; I=INSERTION CODE). REMARK 500 REMARK 500 STANDARD TABLE: REMARK 500 FORMAT:(10X,I3,1X,A3,1X,A1,I4,A1,4X,F7.2,3X,F7.2) REMARK 500 REMARK 500 EXPECTED VALUES: GJ KLEYWEGT AND TA JONES (1996). PHI/PSI- REMARK 500 CHOLOGY: RAMACHANDRAN REVISITED. STRUCTURE 4, 1395 - 1400 REMARK 500 REMARK 500 M RES CSSEQI PSI PHI REMARK 500 ARG A 686 -36.26 -149.22 REMARK 500 GLN A 695 88.55 57.73 REMARK 500 VAL A 697 -172.77 -178.66 REMARK 500 SER A 699 113.32 -162.50 REMARK 500 HIS A 749 54.74 35.15 REMARK 500 GLN A 761 -2.90 75.70 REMARK 500 SER A 771 -70.16 -60.87 REMARK 500 ASP A 815 33.42 -164.24 REMARK 500 ASP A 834 89.47 57.34 REMARK 500 ASP A 843 33.87 -88.02 REMARK 500 VAL A 851 139.86 77.10 REMARK 500 ARG A 853 -52.60 -25.40 REMARK 500 ASP A 867 -139.72 -141.01 REMARK 500 PHE A 918 33.03 -91.44 REMARK 500 ARG A 964 93.66 54.61 REMARK 500 LEU A 984 30.40 -72.97 REMARK 500 ARG B 676 -45.95 86.51 REMARK 500 VAL B 677 128.23 68.08 REMARK 500 ARG B 686 -32.46 -148.97 REMARK 500 PHE B 698 -26.58 79.39 REMARK 500 GLU B 723 -60.74 -19.80 REMARK 500 ASP B 743 78.54 -118.66 REMARK 500 ASP B 746 71.11 55.98 REMARK 500 HIS B 749 56.18 23.14 REMARK 500 GLN B 761 -1.07 70.46 REMARK 500 SER B 771 -71.10 -54.30 REMARK 500 ASP B 815 35.17 -163.58 REMARK 500 ASP B 834 88.37 59.47 REMARK 500 ASN B 844 73.61 36.89 REMARK 500 VAL B 851 139.80 75.27 REMARK 500 ARG B 853 -53.46 -29.58 REMARK 500 ASP B 867 -136.32 -136.44 REMARK 500 GLU B 933 -168.81 -117.60 REMARK 500 GLU B 941 -72.90 -89.06 REMARK 500 LYS B 942 105.82 58.33 REMARK 500 GLN B 963 -77.38 -68.92 REMARK 500 LEU B 965 -121.66 -91.79 REMARK 500 LEU B 984 24.80 -75.24 REMARK 500 REMARK 500 REMARK: NULL REMARK 800 REMARK 800 SITE REMARK 800 SITE_IDENTIFIER: AC1 REMARK 800 EVIDENCE_CODE: SOFTWARE REMARK 800 SITE_DESCRIPTION: BINDING SITE FOR RESIDUE 1EH A 1101 REMARK 800 REMARK 800 SITE_IDENTIFIER: AC2 REMARK 800 EVIDENCE_CODE: SOFTWARE REMARK 800 SITE_DESCRIPTION: BINDING SITE FOR RESIDUE SO4 A 1102 REMARK 800 REMARK 800 SITE_IDENTIFIER: AC3 REMARK 800 EVIDENCE_CODE: SOFTWARE REMARK 800 SITE_DESCRIPTION: BINDING SITE FOR RESIDUE SO4 A 1103 REMARK 800 REMARK 800 SITE_IDENTIFIER: AC4 REMARK 800 EVIDENCE_CODE: SOFTWARE REMARK 800 SITE_DESCRIPTION: BINDING SITE FOR RESIDUE SO4 A 1104 REMARK 800 REMARK 800 SITE_IDENTIFIER: AC5 REMARK 800 EVIDENCE_CODE: SOFTWARE REMARK 800 SITE_DESCRIPTION: BINDING SITE FOR RESIDUE SO4 A 1105 REMARK 800 REMARK 800 SITE_IDENTIFIER: AC6 REMARK 800 EVIDENCE_CODE: SOFTWARE REMARK 800 SITE_DESCRIPTION: BINDING SITE FOR RESIDUE 1EH B 1101 REMARK 800 REMARK 800 SITE_IDENTIFIER: AC7 REMARK 800 EVIDENCE_CODE: SOFTWARE REMARK 800 SITE_DESCRIPTION: BINDING SITE FOR RESIDUE SO4 B 1102 REMARK 800 REMARK 800 SITE_IDENTIFIER: AC8 REMARK 800 EVIDENCE_CODE: SOFTWARE REMARK 800 SITE_DESCRIPTION: BINDING SITE FOR RESIDUE SO4 B 1103 REMARK 900 REMARK 900 RELATED ENTRIES REMARK 900 RELATED ID: 4IAN RELATED DB: PDB REMARK 900 RELATED ID: 4IFC RELATED DB: PDB REMARK 900 RELATED ID: 4IIR RELATED DB: PDB DBREF 4IJP A 657 1007 UNP Q13523 PRP4B_HUMAN 657 1007 DBREF 4IJP B 657 1007 UNP Q13523 PRP4B_HUMAN 657 1007 SEQADV 4IJP MET A 656 UNP Q13523 EXPRESSION TAG SEQADV 4IJP HIS A 1008 UNP Q13523 EXPRESSION TAG SEQADV 4IJP HIS A 1009 UNP Q13523 EXPRESSION TAG SEQADV 4IJP HIS A 1010 UNP Q13523 EXPRESSION TAG SEQADV 4IJP HIS A 1011 UNP Q13523 EXPRESSION TAG SEQADV 4IJP HIS A 1012 UNP Q13523 EXPRESSION TAG SEQADV 4IJP HIS A 1013 UNP Q13523 EXPRESSION TAG SEQADV 4IJP MET B 656 UNP Q13523 EXPRESSION TAG SEQADV 4IJP HIS B 1008 UNP Q13523 EXPRESSION TAG SEQADV 4IJP HIS B 1009 UNP Q13523 EXPRESSION TAG SEQADV 4IJP HIS B 1010 UNP Q13523 EXPRESSION TAG SEQADV 4IJP HIS B 1011 UNP Q13523 EXPRESSION TAG SEQADV 4IJP HIS B 1012 UNP Q13523 EXPRESSION TAG SEQADV 4IJP HIS B 1013 UNP Q13523 EXPRESSION TAG SEQRES 1 A 358 MET ASP PHE LYS GLU ASN PRO ASN LEU ARG ASP ASN TRP SEQRES 2 A 358 THR ASP ALA GLU GLY TYR TYR ARG VAL ASN ILE GLY GLU SEQRES 3 A 358 VAL LEU ASP LYS ARG TYR ASN VAL TYR GLY TYR THR GLY SEQRES 4 A 358 GLN GLY VAL PHE SER ASN VAL VAL ARG ALA ARG ASP ASN SEQRES 5 A 358 ALA ARG ALA ASN GLN GLU VAL ALA VAL LYS ILE ILE ARG SEQRES 6 A 358 ASN ASN GLU LEU MET GLN LYS THR GLY LEU LYS GLU LEU SEQRES 7 A 358 GLU PHE LEU LYS LYS LEU ASN ASP ALA ASP PRO ASP ASP SEQRES 8 A 358 LYS PHE HIS CYS LEU ARG LEU PHE ARG HIS PHE TYR HIS SEQRES 9 A 358 LYS GLN HIS LEU CYS LEU VAL PHE GLU PRO LEU SER MET SEQRES 10 A 358 ASN LEU ARG GLU VAL LEU LYS LYS TYR GLY LYS ASP VAL SEQRES 11 A 358 GLY LEU HIS ILE LYS ALA VAL ARG SER TYR SER GLN GLN SEQRES 12 A 358 LEU PHE LEU ALA LEU LYS LEU LEU LYS ARG CYS ASN ILE SEQRES 13 A 358 LEU HIS ALA ASP ILE LYS PRO ASP ASN ILE LEU VAL ASN SEQRES 14 A 358 GLU SER LYS THR ILE LEU LYS LEU CYS ASP PHE GLY SER SEQRES 15 A 358 ALA SER HIS VAL ALA ASP ASN ASP ILE THR PRO PTR LEU SEQRES 16 A 358 VAL SER ARG PHE TYR ARG ALA PRO GLU ILE ILE ILE GLY SEQRES 17 A 358 LYS SER TYR ASP TYR GLY ILE ASP MET TRP SER VAL GLY SEQRES 18 A 358 CYS THR LEU TYR GLU LEU TYR THR GLY LYS ILE LEU PHE SEQRES 19 A 358 PRO GLY LYS THR ASN ASN HIS MET LEU LYS LEU ALA MET SEQRES 20 A 358 ASP LEU LYS GLY LYS MET PRO ASN LYS MET ILE ARG LYS SEQRES 21 A 358 GLY VAL PHE LYS ASP GLN HIS PHE ASP GLN ASN LEU ASN SEQRES 22 A 358 PHE MET TYR ILE GLU VAL ASP LYS VAL THR GLU ARG GLU SEQRES 23 A 358 LYS VAL THR VAL MET SER THR ILE ASN PRO THR LYS ASP SEQRES 24 A 358 LEU LEU ALA ASP LEU ILE GLY CYS GLN ARG LEU PRO GLU SEQRES 25 A 358 ASP GLN ARG LYS LYS VAL HIS GLN LEU LYS ASP LEU LEU SEQRES 26 A 358 ASP GLN ILE LEU MET LEU ASP PRO ALA LYS ARG ILE SER SEQRES 27 A 358 ILE ASN GLN ALA LEU GLN HIS ALA PHE ILE GLN GLU LYS SEQRES 28 A 358 ILE HIS HIS HIS HIS HIS HIS SEQRES 1 B 358 MET ASP PHE LYS GLU ASN PRO ASN LEU ARG ASP ASN TRP SEQRES 2 B 358 THR ASP ALA GLU GLY TYR TYR ARG VAL ASN ILE GLY GLU SEQRES 3 B 358 VAL LEU ASP LYS ARG TYR ASN VAL TYR GLY TYR THR GLY SEQRES 4 B 358 GLN GLY VAL PHE SER ASN VAL VAL ARG ALA ARG ASP ASN SEQRES 5 B 358 ALA ARG ALA ASN GLN GLU VAL ALA VAL LYS ILE ILE ARG SEQRES 6 B 358 ASN ASN GLU LEU MET GLN LYS THR GLY LEU LYS GLU LEU SEQRES 7 B 358 GLU PHE LEU LYS LYS LEU ASN ASP ALA ASP PRO ASP ASP SEQRES 8 B 358 LYS PHE HIS CYS LEU ARG LEU PHE ARG HIS PHE TYR HIS SEQRES 9 B 358 LYS GLN HIS LEU CYS LEU VAL PHE GLU PRO LEU SER MET SEQRES 10 B 358 ASN LEU ARG GLU VAL LEU LYS LYS TYR GLY LYS ASP VAL SEQRES 11 B 358 GLY LEU HIS ILE LYS ALA VAL ARG SER TYR SER GLN GLN SEQRES 12 B 358 LEU PHE LEU ALA LEU LYS LEU LEU LYS ARG CYS ASN ILE SEQRES 13 B 358 LEU HIS ALA ASP ILE LYS PRO ASP ASN ILE LEU VAL ASN SEQRES 14 B 358 GLU SER LYS THR ILE LEU LYS LEU CYS ASP PHE GLY SER SEQRES 15 B 358 ALA SER HIS VAL ALA ASP ASN ASP ILE THR PRO PTR LEU SEQRES 16 B 358 VAL SER ARG PHE TYR ARG ALA PRO GLU ILE ILE ILE GLY SEQRES 17 B 358 LYS SER TYR ASP TYR GLY ILE ASP MET TRP SER VAL GLY SEQRES 18 B 358 CYS THR LEU TYR GLU LEU TYR THR GLY LYS ILE LEU PHE SEQRES 19 B 358 PRO GLY LYS THR ASN ASN HIS MET LEU LYS LEU ALA MET SEQRES 20 B 358 ASP LEU LYS GLY LYS MET PRO ASN LYS MET ILE ARG LYS SEQRES 21 B 358 GLY VAL PHE LYS ASP GLN HIS PHE ASP GLN ASN LEU ASN SEQRES 22 B 358 PHE MET TYR ILE GLU VAL ASP LYS VAL THR GLU ARG GLU SEQRES 23 B 358 LYS VAL THR VAL MET SER THR ILE ASN PRO THR LYS ASP SEQRES 24 B 358 LEU LEU ALA ASP LEU ILE GLY CYS GLN ARG LEU PRO GLU SEQRES 25 B 358 ASP GLN ARG LYS LYS VAL HIS GLN LEU LYS ASP LEU LEU SEQRES 26 B 358 ASP GLN ILE LEU MET LEU ASP PRO ALA LYS ARG ILE SER SEQRES 27 B 358 ILE ASN GLN ALA LEU GLN HIS ALA PHE ILE GLN GLU LYS SEQRES 28 B 358 ILE HIS HIS HIS HIS HIS HIS MODRES 4IJP PTR A 849 TYR O-PHOSPHOTYROSINE MODRES 4IJP PTR B 849 TYR O-PHOSPHOTYROSINE HET PTR A 849 16 HET PTR B 849 16 HET 1EH A1101 28 HET SO4 A1102 5 HET SO4 A1103 5 HET SO4 A1104 5 HET SO4 A1105 5 HET 1EH B1101 28 HET SO4 B1102 5 HET SO4 B1103 5 HETNAM PTR O-PHOSPHOTYROSINE HETNAM 1EH 4-(5-{[(2-CHLOROPYRIDIN-4-YL)METHYL]CARBAMOYL}THIOPHEN- HETNAM 2 1EH 2-YL)-1-BENZOTHIOPHENE-2-CARBOXAMIDE HETNAM SO4 SULFATE ION HETSYN PTR PHOSPHONOTYROSINE FORMUL 1 PTR 2(C9 H12 N O6 P) FORMUL 3 1EH 2(C20 H14 CL N3 O2 S2) FORMUL 4 SO4 6(O4 S 2-) FORMUL 11 HOH *173(H2 O) HELIX 1 1 ALA A 708 ALA A 710 5 3 HELIX 2 2 ASN A 722 ASP A 743 1 22 HELIX 3 3 LEU A 774 GLY A 782 1 9 HELIX 4 4 HIS A 788 CYS A 809 1 22 HELIX 5 5 LYS A 817 ASP A 819 5 3 HELIX 6 6 SER A 852 ARG A 856 5 5 HELIX 7 7 ALA A 857 GLY A 863 1 7 HELIX 8 8 TYR A 868 GLY A 885 1 18 HELIX 9 9 THR A 893 GLY A 906 1 14 HELIX 10 10 PRO A 909 GLY A 916 1 8 HELIX 11 11 PHE A 918 HIS A 922 5 5 HELIX 12 12 ASP A 954 ILE A 960 1 7 HELIX 13 13 PRO A 966 LEU A 984 1 19 HELIX 14 14 ASP A 987 ARG A 991 5 5 HELIX 15 15 SER A 993 GLN A 999 1 7 HELIX 16 16 ALA B 708 ALA B 710 5 3 HELIX 17 17 ASN B 722 ASP B 743 1 22 HELIX 18 18 LEU B 774 GLY B 782 1 9 HELIX 19 19 HIS B 788 CYS B 809 1 22 HELIX 20 20 LYS B 817 ASP B 819 5 3 HELIX 21 21 SER B 852 ARG B 856 5 5 HELIX 22 22 ALA B 857 GLY B 863 1 7 HELIX 23 23 TYR B 868 GLY B 885 1 18 HELIX 24 24 THR B 893 GLY B 906 1 14 HELIX 25 25 PRO B 909 GLY B 916 1 8 HELIX 26 26 PHE B 918 PHE B 923 1 6 HELIX 27 27 ASP B 954 GLY B 961 1 8 HELIX 28 28 PRO B 966 LEU B 984 1 19 HELIX 29 29 SER B 993 GLN B 999 1 7 HELIX 30 30 HIS B 1000 GLU B 1005 1 6 SHEET 1 A 6 VAL A 682 LEU A 683 0 SHEET 2 A 6 TYR A 687 TYR A 692 -1 O TYR A 687 N LEU A 683 SHEET 3 A 6 VAL A 701 ASP A 706 -1 O ARG A 705 N ASN A 688 SHEET 4 A 6 GLU A 713 ILE A 718 -1 O VAL A 716 N VAL A 702 SHEET 5 A 6 HIS A 762 PHE A 767 -1 O PHE A 767 N ALA A 715 SHEET 6 A 6 LEU A 753 HIS A 759 -1 N PHE A 757 O CYS A 764 SHEET 1 B 3 MET A 772 ASN A 773 0 SHEET 2 B 3 ILE A 821 VAL A 823 -1 O VAL A 823 N MET A 772 SHEET 3 B 3 LEU A 830 LEU A 832 -1 O LYS A 831 N LEU A 822 SHEET 1 C 2 ILE A 811 LEU A 812 0 SHEET 2 C 2 SER A 839 HIS A 840 -1 O SER A 839 N LEU A 812 SHEET 1 D 2 PHE A 929 GLU A 933 0 SHEET 2 D 2 LYS A 942 MET A 946 -1 O THR A 944 N TYR A 931 SHEET 1 E 6 VAL B 682 LEU B 683 0 SHEET 2 E 6 TYR B 687 GLY B 694 -1 O TYR B 687 N LEU B 683 SHEET 3 E 6 SER B 699 ASP B 706 -1 O ARG B 705 N ASN B 688 SHEET 4 E 6 GLU B 713 ILE B 719 -1 O ILE B 718 N ASN B 700 SHEET 5 E 6 HIS B 762 PHE B 767 -1 O PHE B 767 N ALA B 715 SHEET 6 E 6 LEU B 753 HIS B 759 -1 N PHE B 757 O CYS B 764 SHEET 1 F 3 MET B 772 ASN B 773 0 SHEET 2 F 3 ILE B 821 VAL B 823 -1 O VAL B 823 N MET B 772 SHEET 3 F 3 LEU B 830 LEU B 832 -1 O LYS B 831 N LEU B 822 SHEET 1 G 2 ILE B 811 LEU B 812 0 SHEET 2 G 2 SER B 839 HIS B 840 -1 O SER B 839 N LEU B 812 SHEET 1 H 2 PHE B 929 ILE B 932 0 SHEET 2 H 2 VAL B 943 MET B 946 -1 O THR B 944 N TYR B 931 LINK C PRO A 848 N PTR A 849 1555 1555 1.35 LINK C PTR A 849 N LEU A 850 1555 1555 1.35 LINK C PRO B 848 N PTR B 849 1555 1555 1.34 LINK C PTR B 849 N LEU B 850 1555 1555 1.35 CISPEP 1 GLY A 696 VAL A 697 0 -7.44 CISPEP 2 GLN B 695 GLY B 696 0 -0.59 CISPEP 3 GLY B 696 VAL B 697 0 -0.30 SITE 1 AC1 13 THR A 693 VAL A 701 ARG A 703 ALA A 715 SITE 2 AC1 13 LYS A 717 GLU A 768 LEU A 770 SER A 771 SITE 3 AC1 13 MET A 772 GLU A 776 LEU A 822 HOH A1233 SITE 4 AC1 13 HOH A1271 SITE 1 AC2 3 ARG A 686 ARG A 709 ARG B 709 SITE 1 AC3 3 PTR A 849 ARG A 853 ARG A 856 SITE 1 AC4 3 LYS A 804 ARG A 808 LYS B 990 SITE 1 AC5 3 LYS A 747 PHE A 748 ARG A 808 SITE 1 AC6 10 THR B 693 VAL B 701 ARG B 703 ALA B 715 SITE 2 AC6 10 LYS B 717 LEU B 770 SER B 771 MET B 772 SITE 3 AC6 10 GLU B 776 LEU B 822 SITE 1 AC7 4 PTR B 849 ARG B 853 ARG B 856 HOH B1213 SITE 1 AC8 2 LYS B 804 ARG B 808 CRYST1 52.140 52.540 79.130 102.56 105.25 92.29 P 1 2 ORIGX1 1.000000 0.000000 0.000000 0.00000 ORIGX2 0.000000 1.000000 0.000000 0.00000 ORIGX3 0.000000 0.000000 1.000000 0.00000 SCALE1 0.019179 0.000767 0.005568 0.00000 SCALE2 0.000000 0.019048 0.004636 0.00000 SCALE3 0.000000 0.000000 0.013481 0.00000